358 related articles for article (PubMed ID: 29878355)
41. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
[TBL] [Abstract][Full Text] [Related]
42. The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma.
Wu W; He J; Cameron JL; Makary M; Soares K; Ahuja N; Rezaee N; Herman J; Zheng L; Laheru D; Choti MA; Hruban RH; Pawlik TM; Wolfgang CL; Weiss MJ
Ann Surg Oncol; 2014 Sep; 21(9):2873-81. PubMed ID: 24770680
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection.
Ren W; Xourafas D; Ashley SW; Clancy TE
Am Surg; 2022 Jun; 88(6):1172-1180. PubMed ID: 33522271
[TBL] [Abstract][Full Text] [Related]
44. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
[TBL] [Abstract][Full Text] [Related]
45. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
46. Survival effects of adjuvant gemcitabine plus S-1 chemotherapy on pancreatic carcinoma stratified by preoperative resectability status.
Murakami Y; Uemura K; Hashimoto Y; Kondo N; Nakagawa N; Takahashi S; Shintakuya R; Sueda T
J Surg Oncol; 2016 Mar; 113(4):405-12. PubMed ID: 26750513
[TBL] [Abstract][Full Text] [Related]
47. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
Cools KS; Sanoff HK; Kim HJ; Yeh JJ; Stitzenberg KB
J Surg Oncol; 2018 Sep; 118(3):455-462. PubMed ID: 30114330
[TBL] [Abstract][Full Text] [Related]
48. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
[TBL] [Abstract][Full Text] [Related]
49. Adjuvant chemotherapy omission after pancreatic cancer resection: a French nationwide study.
Poiraud C; Lenne X; Bruandet A; Theis D; Bertrand N; Turpin A; Truant S; El Amrani M
World J Surg Oncol; 2024 May; 22(1):123. PubMed ID: 38711136
[TBL] [Abstract][Full Text] [Related]
50. Microvascular invasion is a major prognostic factor after pancreatico-duodenectomy for adenocarcinoma.
Panaro F; Kellil T; Vendrell J; Sega V; Souche R; Piardi T; Leon P; Cassinotto C; Assenat E; Rosso E; Navarro F
J Surg Oncol; 2019 Sep; 120(3):483-493. PubMed ID: 31197842
[TBL] [Abstract][Full Text] [Related]
51. Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?
de Carvalho LFA; Gryspeerdt F; Rashidian N; Van Hove K; Maertens L; Ribeiro S; Hoorens A; Berrevoet F
BMC Surg; 2023 Sep; 23(1):296. PubMed ID: 37775737
[TBL] [Abstract][Full Text] [Related]
52. Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series.
Ohgi K; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Aramaki T; Uesaka K
Ann Surg Oncol; 2017 Sep; 24(9):2752-2761. PubMed ID: 28685356
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
Nanashima A; Tobinaga S; Abo T; Hatano K; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741
[TBL] [Abstract][Full Text] [Related]
54. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
55. Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas.
Kang CM; Kim DH; Choi GH; Kim KS; Choi JS; Lee WJ
J Gastrointest Surg; 2009 May; 13(5):907-14. PubMed ID: 19224295
[TBL] [Abstract][Full Text] [Related]
56. Major Complications Independently Increase Long-Term Mortality After Pancreatoduodenectomy for Cancer.
Sandini M; Ruscic KJ; Ferrone CR; Qadan M; Eikermann M; Warshaw AL; Lillemoe KD; Castillo CF
J Gastrointest Surg; 2019 Oct; 23(10):1984-1990. PubMed ID: 30225794
[TBL] [Abstract][Full Text] [Related]
57. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
Lewis R; Drebin JA; Callery MP; Fraker D; Kent TS; Gates J; Vollmer CM
HPB (Oxford); 2013 Jan; 15(1):49-60. PubMed ID: 23216779
[TBL] [Abstract][Full Text] [Related]
58. Survival impact based on hepatic artery lymph node status in pancreatic adenocarcinoma: A study of patients receiving modern chemotherapy.
Perlmutter BC; Hossain MS; Naples R; Tu C; Vilchez V; McMichael J; Tullio K; Simon R; Walsh RM; Augustin T
J Surg Oncol; 2021 Feb; 123(2):399-406. PubMed ID: 33159317
[TBL] [Abstract][Full Text] [Related]
59. The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Welsch T; Degrate L; Zschäbitz S; Hofer S; Werner J; Schmidt J
Langenbecks Arch Surg; 2011 Mar; 396(3):353-62. PubMed ID: 20336311
[TBL] [Abstract][Full Text] [Related]
60. Effect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer.
Le AT; Huang B; Hnoosh D; Saeed H; Dineen SP; Hosein PJ; Durbin EB; Kudrimoti M; McGrath PC; Tzeng CD
J Surg Res; 2017 Jun; 214():1-8. PubMed ID: 28624029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
